Literature DB >> 23399461

Illicit drugs: What dermatologists need to know.

Cara Hennings1, Jami Miller.   

Abstract

We review the most common systemic and cutaneous signs of heroin, cocaine, methamphetamine, Ecstasy, and marijuana use. We also provide an overview of the skin and soft-tissue infections frequently found in intravenous drug users and the effects of the adulterants added to the drugs.
Copyright © 2012 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23399461     DOI： 10.1016/j.jaad.2012.12.968

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


  5 in total

1.  Emerging and Underrecognized Complications of Illicit Drug Use.

Authors:  Alysse G Wurcel; Elisabeth A Merchant; Roger P Clark; David R Stone
Journal:  Clin Infect Dis       Date:  2015-08-12       Impact factor: 9.079

2.  Prevalence and Pattern of Dermatological Manifestations Among Substance Users Across Kashmir Valley in North India.

Authors:  Aaqib Aslam; Shagufta Rather; Arshad Hussain; Faizan Younus; Najam U Saqib; Iffat Hassan
Journal:  Indian Dermatol Online J       Date:  2022-06-24

3.  Ecstasy-induced fixed drug eruption.

Authors:  Ophélie Barbier; Alia Galadari; Brigitte Milpied; Paola Sanchez; Stéphanie Kassab; Ruben Goncalves; Anne-Sophie Darrigade
Journal:  Contact Dermatitis       Date:  2022-04-29       Impact factor: 6.419

Review 4.  Soft Tissue, Bone, and Joint Infections in People Who Inject Drugs.

Authors:  Carlos S Saldana; Darshali A Vyas; Alysse G Wurcel
Journal:  Infect Dis Clin North Am       Date:  2020-09       Impact factor: 5.982

5.  The Use of Illegal Drugs and Infectious Contagious Diseases: Knowledge and Intervention among Dockworkers.

Authors:  Marta Regina Cezar-Vaz; Clarice Alves Bonow; Mara Regina Santos da Silva; Francisca Lucélia Ribeiro de Farias; Marlise Capa Verde de Almeida
Journal:  Int J Environ Res Public Health       Date:  2016-01-12       Impact factor: 3.390
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.